W1329 Patients With Mild-to-Moderate Ulcerative Colitis Experience Symptom Improvement 1 Week After Commencing Treatment With MMX® Mesalamine 2.4g/Day for Induction of Remission

✍ Scribed by Kane, Sunanda V.; Solomon, Dory M.; Palmen, Mary; Barrett, Karen

• Book ID: 122665752
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 62 KB
• Volume: 138
• Category: Article
• ISSN: 0016-5085
• DOI: 10.1016/S0016-5085(10)63220-9